Blake R. Wilde

857 total citations
14 papers, 584 citations indexed

About

Blake R. Wilde is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Blake R. Wilde has authored 14 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Blake R. Wilde's work include Cancer, Hypoxia, and Metabolism (7 papers), Renal cell carcinoma treatment (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Blake R. Wilde is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Renal cell carcinoma treatment (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Blake R. Wilde collaborates with scholars based in United States, Canada and United Kingdom. Blake R. Wilde's co-authors include Donald E. Ayer, Mohan R. Kaadige, Alana L. Welm, Liangliang Shen, Adam L. Cohen, John O'shea, Heather R. Christofk, Thomas Q. de Aguiar Vallim, Mark S. Sharpley and David B. Shackelford and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Blake R. Wilde

14 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Blake R. Wilde United States 10 419 242 117 82 59 14 584
Alina De Donatis Italy 4 412 1.0× 348 1.4× 177 1.5× 83 1.0× 54 0.9× 5 697
Ruben Martherus Belgium 10 496 1.2× 400 1.7× 91 0.8× 44 0.5× 62 1.1× 14 741
Haiping Pei China 13 321 0.8× 199 0.8× 141 1.2× 51 0.6× 70 1.2× 20 525
Kelsey Weigel United States 8 373 0.9× 173 0.7× 172 1.5× 78 1.0× 82 1.4× 11 604
Byung–Kyu Ryu South Korea 10 374 0.9× 120 0.5× 135 1.2× 59 0.7× 62 1.1× 11 562
Amar Desai United States 11 386 0.9× 157 0.6× 185 1.6× 39 0.5× 52 0.9× 23 599
Sun Y. Kim United States 6 319 0.8× 168 0.7× 174 1.5× 51 0.6× 52 0.9× 6 571
Margarite D. Matossian United States 14 314 0.7× 136 0.6× 258 2.2× 42 0.5× 50 0.8× 39 588
Yongtian Lu China 12 277 0.7× 260 1.1× 131 1.1× 37 0.5× 108 1.8× 36 641
Chongru Zhao China 14 445 1.1× 303 1.3× 120 1.0× 28 0.3× 49 0.8× 23 701

Countries citing papers authored by Blake R. Wilde

Since Specialization
Citations

This map shows the geographic impact of Blake R. Wilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake R. Wilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake R. Wilde more than expected).

Fields of papers citing papers by Blake R. Wilde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blake R. Wilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake R. Wilde. The network helps show where Blake R. Wilde may publish in the future.

Co-authorship network of co-authors of Blake R. Wilde

This figure shows the co-authorship network connecting the top 25 collaborators of Blake R. Wilde. A scholar is included among the top collaborators of Blake R. Wilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blake R. Wilde. Blake R. Wilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wilde, Blake R., Fadi Brimo, Heather R. Christofk, et al.. (2024). Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase (FH) as pathogenic. Genes Chromosomes and Cancer. 63(2). e23221–e23221. 2 indexed citations
2.
Wilde, Blake R., Serena Lofftus, Tyler R. McCaw, et al.. (2024). Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated Liposarcoma. Cancers. 16(17). 3031–3031. 2 indexed citations
3.
Wilde, Blake R., Daiki Ueno, Edward D. Esplin, et al.. (2023). FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer. Cancer Discovery. 13(9). 2072–2089. 19 indexed citations
4.
Jacobson, Elsie, Hannah Sunshine, Blake R. Wilde, et al.. (2023). ZFP36-mediated mRNA decay regulates metabolism. Cell Reports. 42(5). 112411–112411. 17 indexed citations
5.
Lu, Eric, Paul C. Boutros, Liying Zhang, et al.. (2023). Fumarate Hydratase Variants and Their Association With Paraganglioma/Pheochromocytoma. Urology. 176. 106–114. 6 indexed citations
6.
Wilde, Blake R., Kristin Murphy, Jeffery M. Vahrenkamp, et al.. (2023). TXNIP loss expands Myc-dependent transcriptional programs by increasing Myc genomic binding. PLoS Biology. 21(3). e3001778–e3001778. 4 indexed citations
7.
Lu, Eric, Kathryn E. Hatchell, Sarah M. Nielsen, et al.. (2021). Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing. Cancer. 128(4). 675–684. 16 indexed citations
8.
Wilde, Blake R., Mohan R. Kaadige, Katrin P. Guillen, et al.. (2020). Protein synthesis inhibitors stimulate MondoA transcriptional activity by driving an accumulation of glucose 6-phosphate. SHILAP Revista de lepidopterología. 8(1). 27–27. 10 indexed citations
10.
Sullivan, William J., Peter Mullen, E. Schmid, et al.. (2018). Extracellular Matrix Remodeling Regulates Glucose Metabolism through TXNIP Destabilization. Cell. 175(1). 117–132.e21. 194 indexed citations
11.
Wilde, Blake R. & Donald E. Ayer. (2015). Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis. British Journal of Cancer. 113(11). 1529–1533. 48 indexed citations
12.
Shen, Liangliang, John O'shea, Mohan R. Kaadige, et al.. (2015). Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP. Proceedings of the National Academy of Sciences. 112(17). 5425–5430. 179 indexed citations
13.
Kaadige, Mohan R., et al.. (2014). MondoA-Mlx Transcriptional Activity Is Limited by mTOR-MondoA Interaction. Molecular and Cellular Biology. 35(1). 101–110. 30 indexed citations
14.
Clayton, Christopher, et al.. (2013). Characteristics and CLOU Performance of a Novel SiO2-Supported Oxygen Carrier Prepared from CuO and β-SiC. Energy & Fuels. 27(10). 6040–6047. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026